A research report on Japan's weight management market has been released. The market is valued at approximately US$7.22 billion as of 2025 and is projected to expand to approximately US$15.88 billion by 2035, with an estimated CAGR of approximately 8.2%.
In terms of market size trends, Japan's weight management market is expected to reach approximately US$7.22 billion as of 2025, expand at a CAGR of 8.2% from 2026 to 2035, and reach approximately US$15.88 billion by 2035. Key growth drivers include rising health awareness, the growing adoption of digital health, and the approval and launch of new obesity treatments.
Diet is the largest segment of the market, accounting for approximately 70% of sales, or 71.94%. This segment includes related categories such as supplements, low-calorie foods, and diet beverages, reflecting the ways in which weight management is integrated into daily life.
The adoption of prescription drugs could reshape the competitive dynamics of the market. In 2024, Novo Nordisk's Wegovy was launched in Japan, and in December of the same year, Eli Lilly Japan and Mitsubishi Tanabe Pharma obtained marketing approval for Zepbound. These developments are expected to support the growth of medical obesity treatment as a high-value segment.
While digital services such as online weight-loss programs, fitness equipment, and digital health integration are becoming increasingly important, the market is expected to shift away from its traditional focus on food, exercise, and supplements.
The competitive landscape includes Nutrisystem, WW International, Kellogg, and Nestlé, while Wegovy and Zepbound are presented as the central drivers of market growth.